Hal Walsh

Hal Walsh has a long and varied career in the pharmaceutical industry. Hal began their career in 1985 as a Sales Representative for Curtin Matheson Scientific. Hal then moved up to Sales and Marketing Manager for Labcraft, Clinical Sales Manager, and Vice President/General Manager for MedPath. In 1994, they became the Director of Corporate Accounts for Thermo Fisher Scientific/Curtin Matheson Scientific. In 1996, they were promoted to Director of Sales for Bard Diagnostic Sciences at CR Bard. In 1998, they were promoted to Vice President of Primary Care North at McKesson. In 2004, they became the Managing Director of the Carolinas Business Unit at Quest Diagnostics. In 2006, they became the Vice President of Sales and Marketing at RedPath Integrated Pathology. Hal also served as a consultant for TriPath Imaging, Inc. in 2006. In 2007, they became the President of Walsh+Company and in 2018, they became the CEO of SymmetryRx, where they own, develops, and operates software platforms (SaaS) to manage drug sample requests.

Hal Walsh attended Villanova University from 1981 to 1985, where they earned a Bachelor of Science in Business Administration from the Villanova School of Business (VSB) with a focus in Finance.